Company Overview
Snapshot
Founded in March 2019 by Achiau Ludomirsky, Yaron Lipman, and Itay Kezurer, UltraSight operates with 11–50 employees. The company has raised $15.2 million across 4 funding rounds from 4 investors. In June 2024, UltraSight collaborated with Mayo Clinic to advance next-generation cardiac care with AI.
Business overview
UltraSight is a Health Tech & Life Sciences company focused on making diagnostic imaging more accessible through AI-driven software. The company's core technology provides real-time guidance for cardiac ultrasound devices, enabling medical professionals to acquire timely and accurate cardiac images. UltraSight serves the healthcare industry, specifically targeting healthcare providers in the digital medical diagnostics sector, with a focus on cardiology.
Strategic signal
In June 2024, UltraSight announced a collaboration with Mayo Clinic to advance next-generation cardiac care using AI. This partnership signals strong strategic validation for UltraSight's technology, demonstrating its potential to integrate with leading medical institutions and accelerate the adoption of AI-powered cardiac ultrasound solutions in clinical practice.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent partnership for UltraSight?
- In June 2024, UltraSight collaborated with Mayo Clinic to advance next-generation cardiac care with AI, focusing on enhancing cardiac ultrasound capabilities.
- When did UltraSight receive FDA clearance for its AI-powered cardiac ultrasound technology?
- In July 2023, the FDA granted clearance for UltraSight's AI-powered cardiac ultrasound technology, enabling its use in the United States.
- What was the outcome of the landmark study involving UltraSight's technology?
- A landmark study published in November 2022 indicated that UltraSight's technology enables novice ultrasound users to capture high-quality cardiac images, demonstrating its effectiveness in broadening access to diagnostic imaging.
- Which firm is bringing UltraSight's Israeli ultrasound software to the Korean market?
- In February 2024, a Korean firm began bringing UltraSight's Israeli ultrasound software to the local market, expanding the company's international reach.
- When was UltraSight granted a patent for its real-time guidance ultrasound technology?
- UltraSight was granted a patent for its real-time guidance ultrasound technology in February 2023, protecting its innovative approach to cardiac imaging.